Baxter International | BAX - 売上総利益

株価
16.97
毎日の変更
0.22 1.31%
毎月
2.11%
毎年
-44.76%
Q2 予測
16.85




売上総利益 変化する 日付
Abbott USD 5.86B 675M 2026-03
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Avanos Medical USD 94.2M 8.2M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Fresenius EUR 1.51B 214M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
ICU Medical USD 202.98M 2.1M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 184.8M 10.56M 2026-03
Quest Diagnostics USD 906M 33M 2026-03
Smith & Nephew USD 2.09B 117M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12